(Health-NewsWire.Net, June 04, 2017 ) Oncgnostics GmbH (Oncgnostics) is an in-vitro diagnostic company that specializes in the development of in-vitro diagnostic tests for the therapeutics area of cancer. The company's pipeline offers GynTect technology, a system based on the detection of epigenetic biomarkers, mainly in the methylation of specific DNA regions. Its GynTect allows a fast and reliable detection of cervical precancerous lesions and cancer. The company's pipeline focuses on applications in the fields that include ovarian cancer and head-and-neck tumors. It also specializes in the IVD test development field at, after test validation and initial preclinical trials, and others. Oncgnostics is headquartered in Jena, Germany.
This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.
Request Free Sample Report - http://www.marketresearchhub.com/enquiry.php?type=S&repid=1107608
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments - The report analyzes all pipeline products in development for the company Oncgnostics GmbH - The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status) - The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date - The report provides detailed description of products in development, technical specification and functions - The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape - Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio - To formulate effective Research & Development strategies - Develop market-entry and market expansion strategies - Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc - Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Browse Full Report with TOC - http://www.marketresearchhub.com/report/oncgnostics-gmbh-product-pipeline-analysis-2017-update-report.html
Table of Contents Table of Contents 2 List of Tables 3 List of Figures 3 Oncgnostics GmbH Company Overview 4 Oncgnostics GmbH Company Snapshot 4 Oncgnostics GmbH Pipeline Products and Ongoing Clinical Trials Overview 4 Oncgnostics GmbH Pipeline Analysis Overview 7 Oncgnostics GmbH - Key Facts 7 Oncgnostics GmbH - Major Products and Services 8 Oncgnostics GmbH Pipeline Products by Development Stage 9 Oncgnostics GmbH Pipeline Products Overview 11 GynTect 11 GynTect Product Overview 11 GynTect 2.0 12 GynTect 2.0 Product Overview 12 Oncgnostics Diagnostic Test - Head & Neck Cancer 13 Oncgnostics Diagnostic Test - Head & Neck Cancer Product Overview 13 Oncgnostics Diagnostic Test - Ovarian Cancer 14 Oncgnostics Diagnostic Test - Ovarian Cancer Product Overview 14 Oncgnostics GmbH - Key Competitors 15 Oncgnostics GmbH - Key Employees 16 Oncgnostics GmbH - Locations And Subsidiaries 17 Head Office 17 Recent Developments 18 Oncgnostics GmbH, Recent Developments 18 Sep 20, 2016: Early Detection of Ervical cancer: GynTect 2.0- Wider Range of Application by Using a Greater Variety of Patient Samples 18 Apr 28, 2016: Oncgnostics cooperates with SAYRE Therapeutics in India 18
Make an Enquiry - http://www.marketresearchhub.com/enquiry.php?type=enquiry&repid=1107608
About Market Research Hub
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
Contact Us 90 State Street, Albany, NY 12207, United States Toll Free : 866-997-4948 (US-Canada) Tel : +1-518-621-2074 Email : press@marketresearchhub.com Website : http://www.marketresearchhub.com/ Read Industry News at - https://www.industrynewsanalysis.com/
Market Research Hub
Sudip S
+1-518-621-2074
sales@marketresearchhub.com
Source: EmailWire.Com
|